Patent details
EP3624786 Title: A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER
Basic Information
- Publication number:
- EP3624786
- PCT Application Number:
- EP2018062554
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187226212
- PCT Publication Number:
- WO2018210830
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER
- French Title of Invention:
- COMBINAISON PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- PHARMAZEUTISCHE KOMBINATIONEN ZUR BEHANDLUNG VON KREBS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/07/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 14/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/07/2023
- Unitary Effect Registration Date:
- 14/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 15/05/2018
- Grant date:
- 05/07/2023
- EP Publication Date:
- 25/03/2020
- PCT Publication Date:
- 22/11/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/07/2023
- EP B1 Publication Date:
- 05/07/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/05/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/07/2023
- Name:
- Ability Pharmaceuticals S.A.
- Address:
- Parc de Recerca UAB Campus UAB s/n Edifici Eureka - Bellaterra, 08193 Cerdanyola del Vallès, Spain (ES)
History of Owners
- From:
- 28/06/2023
- To:
- 28/07/2023
- Name:
- Ability Pharmaceuticals S.L.
- Address:
- Parc de Recerca UAB Campus UAB s/n Edifici Eureka - Bellaterra, 08193 Cerdanyola del Vallès, Spain (ES)
Inventor
1
- Name:
- MIGUEL LIZCANO DE VEGA, Jose
- Address:
- Spain (ES)
2
- Name:
- FRANCISCO SEGURA GINARD, Miguel
- Address:
- Spain (ES)
3
- Name:
- PÉREZ MONTOYO, Héctor
- Address:
- Spain (ES)
4
- Name:
- ALBERTO ALFÓN CORIAT, José
- Address:
- Spain (ES)
5
- Name:
- DOMÈNECH GARCIA, Carles
- Address:
- Spain (ES)
Priority
- Priority Number:
- 17382282
- Priority Date:
- 16/05/2017
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/201; A61K 31/337; A61K 31/555; A61K 31/7068; A61K 31/203; A61K 31/519; A61K 33/24; A61K 33/243; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202327
- Publication date:
- 05/07/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202329
- Publication date:
- 19/07/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202333
- Publication date:
- 16/08/2023
- Description:
- Unitary Effect Request Acceptance
5
- Issue number:
- 202335
- Publication date:
- 30/08/2023
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|